InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
0.00%
)
US TECH 100
19,214.40
(
-0.23%
)
Dow Jones
39,134.76
(
0.00%
)
Brent Oil
84.96
(
-0.06%
)
Bitcoin
63,711.26
(
-1.71%
)
Post# of 252281
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: RockRat post# 223109

Friday, 01/11/2019 2:33:10 PM

Friday, January 11, 2019 2:33:10 PM

Post# of 252281
Re: JNCE

The obvious caveat is that there was preclinical data to support the PD-1 combo, but they barely got a signal



Interesting. When I looked into this one, my personal conclusion was that the preclinical data rationalized a CTLA-4 combination but did not support a PD-(L)1 combination.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up